The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s AntiParkinson Drugs Global Market Report 2023, The global antiparkinson drugs market is expected to grow from $9.64 billion in 2022 to $10.23 billion in 2023 at a compound annual growth rate (CAGR) of 6.2%. The market size of the global antiparkinson drugs is expected to grow to $12.37 billion in 2027 at a CAGR of 4.9%.

What was the major driver in the antiparkinson drugs market?
The increasing geriatric population and surging cases of Parkinson’s disease (PD) are projected to drive the demand for the anti-Parkinson drugs market. PD commonly occurs in people over the age of 60 cases of Parkinson’s disease (PD) are projected to drive the demand for the anti-Parkinson drugs market. PD commonly occurs in people over the age of 60. For instance, in June 2020, according to a study by the United Nations, the total number of people age 80 and above is expected to increase from 143 million in 2019 to over 426 million in 2050. Also, in February 2020, Harvard University, a US-based academic university specializing in teaching, learning, and research, will announce that, according to the Parkinson’s Foundation, there are more than 10 million people living with Parkinson’s disease globally, and this year, there will be close to one million cases in the United States. Degeneration of neurons in the geriatric population and the surge in cases of Parkinson’s disease are therefore driving market growth.

View More On The AntiParkinson Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report

What was the key trend in the antiparkinson drugs market?
Increased government and corporate investment in Parkinson’s disease drug R&D is a major trend in the anti-Parkinson drugs market. For instance, in August 2022, the Parkinson’s Foundation, a US-based national organization that provides funding for research and educational resources, will make a $5.7 million investment in 33 projects to speed up cutting-edge research on Parkinson’s disease (PD). Through research grants, the Foundation helps scientists carry out creative studies on numerous PD-related topics in an effort to develop novel therapies, treatments, and ultimately a cure for the 10 million people who suffer from this crippling neurological condition worldwide. Hence, increasing investments in Parkinson’s drug development are expected to drive anti-Parkinson’s drugs market.

Which was the largest region in the antiparkinson drugs market?
North America was the largest region in the anti-Parkinson drugs market in 2022. Middle East is expected to be the fastest-growing region in the global anti-parkinson drugs market during the forecast period. The regions covered in the global anti-Parkinson drugs market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Who are the antiparkinson drugs market prominent players?
Major players in the anti-Parkinson drugs market are GlaxoSmithKline PLC., Pfizer, Merck, Novartis, Roche, UCB S.A, Teva Pharmaceuticals, AbbVie Inc., Mylan, Boehringer Ingelheim, Orion Pharma, ACADIA Pharmaceuticals Inc., Sun Pharma, Wockhardt, Dr. Reddy’s, Intas, US WorldMeds, Zydus Cadila, Cipla, Strides, 1 A Pharma, Upsher-Smith, Lundbeck, Vertical Pharmaceuticals, LLC., Zambon Pharmaceuticals, and M Somerset Pharmaceuticals Inc., and Wockhardt.

Key antiparkinson drugs market segments
The global antiparkinson drugs market is segmented –
1) By Drugs Class: Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-Inhibitors, Anticholinergics, Other Drugs
2) By Route of Administration: Oral, Injection, Transdermal
3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies

Request A Sample Of The Global AntiParkinson Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=3462&type=smp

The AntiParkinson Drugs Global Market Report 2023  provides a comprehensive overview on the antiparkinson drugs market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Antiobesity Global Market Report 2023
Antisense & RNAi Therapeutics Global Market Report 2023
Alzheimer’s Disease Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model